China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
China Traditional Chinese Medicine Holdings Co Ltd
EPS (Diluted)
China Traditional Chinese Medicine Holdings Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
-24%
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
EPS (Diluted)
HK$0
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
EPS (Diluted)
¥1
|
CAGR 3-Years
39%
|
CAGR 5-Years
30%
|
CAGR 10-Years
16%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-37%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
EPS (Diluted)
HK$0
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
EPS (Diluted)
$0
|
CAGR 3-Years
42%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
China Traditional Chinese Medicine Holdings Co Ltd
Glance View
China Traditional Chinese Medicine Holdings Co Ltd sits at the crossroads of ancient wisdom and modern commerce. Rooted deeply in the rich heritage of Traditional Chinese Medicine (TCM), this company skillfully crafts a range of products that cater to both domestic and international markets. At the core of its operations is the cultivation and processing of Chinese medicinal herbs, which are transformed into a wide portfolio of products, including ready-to-use TCM formula granules, patented medicines, and healthcare products. By leveraging its extensive network of cultivation bases, the company ensures the authenticity and quality of its raw materials, an essential component in a sector where the efficacy of products is deeply entwined with their origins. The company’s business model thrives on vertical integration, which allows it to exercise control over the entire supply chain—from the sourcing of raw materials to the manufacturing and distribution processes. Through this multifaceted approach, China Traditional Chinese Medicine Holdings Co Ltd maximizes its profit margins while maintaining stringent quality standards, crucial in a market where consumer trust is paramount. The firm's robust distribution network spans pharmacies, hospitals, and retail outlets, supplemented by a growing e-commerce presence. As healthcare trends increasingly lean towards natural and holistic remedies around the globe, the company finds itself well-positioned to not only cater to traditional markets but also to explore new opportunities in alternative medicine sectors worldwide.
See Also
What is China Traditional Chinese Medicine Holdings Co Ltd's EPS (Diluted)?
EPS (Diluted)
0
CNY
Based on the financial report for Dec 31, 2024, China Traditional Chinese Medicine Holdings Co Ltd's EPS (Diluted) amounts to 0 CNY.
What is China Traditional Chinese Medicine Holdings Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-24%
Over the last year, the EPS (Diluted) growth was -96%. The average annual EPS (Diluted) growth rates for China Traditional Chinese Medicine Holdings Co Ltd have been -70% over the past three years , -50% over the past five years , and -24% over the past ten years .
You don't have any saved screeners yet